Materialise Resultados de beneficios anteriores
Pasado controles de criterios 3/6
Materialise ha aumentado sus beneficios a una tasa media anual de 15.1%, mientras que los beneficios de la industria de Software han experimentado un crecimiento de 27.4% anual. Los ingresos han ido creciendo a una tasa media de 7.7% al año. La rentabilidad financiera de Materialise es de 3.9%, y sus márgenes netos son de 3.8%.
Información clave
15.15%
Tasa de crecimiento de los beneficios
14.99%
Tasa de crecimiento del BPA
| Crecimiento de la industria Software | 17.33% |
| Tasa de crecimiento de los ingresos | 7.71% |
| Rentabilidad financiera | 3.94% |
| Margen neto | 3.76% |
| Próxima actualización de resultados | 27 Aug 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Seeking Alpha • Jul 22
Materialise: Maturing Transition Should Lead To Stronger Performance Going Forward
Summary While Materialise's Q1 results were soft, its Medical segment appears to be stabilizing and the software business model transition is nearing completion. Cost discipline and a return to growth should see margins start to consistently move higher, assuming that the macro environment remains stable. Despite the stock moving higher in recent months, a material improvement in performance still isn't priced into the stock. Read the full article on Seeking Alpha
Nueva narrativa • Jun 01
Medical And Software Expansion Will Drive Stronger Margins And Earnings Durability
Catalysts About Materialise Materialise provides 3D printing software and services, with a particular focus on medical applications and industrial manufacturing. What are the underlying business or industry changes driving this perspective?
Nueva narrativa • May 17
Cloud Software And Medical Constraints Will Pressure 3D Printing Adoption Yet Offer Gradual Upside
Catalysts About Materialise Materialise provides software and manufacturing solutions for 3D printing, with a particular focus on medical applications, industrial production and related services. What are the underlying business or industry changes driving this perspective?Artículo de análisis • Nov 05
Materialise's (NASDAQ:MTLS) Sluggish Earnings Might Be Just The Beginning Of Its Problems
The market rallied behind Materialise NV's ( NASDAQ:MTLS ) stock, leading do a rise in the share price after its recent...Artículo de análisis • Oct 06
Materialise NV's (NASDAQ:MTLS) P/E Is On The Mark
With a price-to-earnings (or "P/E") ratio of 54.9x Materialise NV ( NASDAQ:MTLS ) may be sending very bearish signals...Artículo de análisis • Jul 27
Analyst Estimates: Here's What Brokers Think Of Materialise NV (NASDAQ:MTLS) After Its Second-Quarter Report
Shareholders might have noticed that Materialise NV ( NASDAQ:MTLS ) filed its quarterly result this time last week. The...Artículo de análisis • Jul 25
Materialise (NASDAQ:MTLS) Is Looking To Continue Growing Its Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Artículo de análisis • May 04
After Leaping 28% Materialise NV (NASDAQ:MTLS) Shares Are Not Flying Under The Radar
Those holding Materialise NV ( NASDAQ:MTLS ) shares would be relieved that the share price has rebounded 28% in the...Seeking Alpha • Feb 24
Materialise: Manufacturing Headwinds Are A Distraction
Summary Materialise's share price dropped significantly after the company reported poor Q4 earnings, which were driven by European automotive market weakness. Despite recent challenges, Materialise's Medical segment continues to perform well and the transition of the Software segment to a subscription model is progressing. The Medical and Software segments are Materialise's primary value drivers and more than justify the company's current valuation. Issues with the Manufacturing segment may need to be resolved before the stock moves higher though. Read the full article on Seeking AlphaArtículo de análisis • Feb 13
Materialise NV's (NASDAQ:MTLS) P/E Is Still On The Mark Following 26% Share Price Bounce
Materialise NV ( NASDAQ:MTLS ) shareholders have had their patience rewarded with a 26% share price jump in the last...
Nueva narrativa • Feb 09
Launch Of Mimics Flow And ACTech Expansion Will Advance Personalized Medicine
Focus on personalized medical solutions and enhanced platforms could drive revenue growth and improve operational efficiencies and net margins.Artículo de análisis • Jan 31
Materialise NV (NASDAQ:MTLS) Shares Could Be 28% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Materialise fair value estimate is US$6.77 Materialise is...Artículo de análisis • Jan 07
These 4 Measures Indicate That Materialise (NASDAQ:MTLS) Is Using Debt Safely
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Nov 07
Materialise NV's (NASDAQ:MTLS) 27% Jump Shows Its Popularity With Investors
Materialise NV ( NASDAQ:MTLS ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...Seeking Alpha • Nov 04
Materialise: Strong Q3 Results Despite Ongoing Market Headwinds
Summary Materialise continues to grow on the back of its Medical segment, which is expanding at a rapid pace. Materialise's margins will continue to improve going forward, driven by a combination of revenue mix and economies of scale. The ACTech plant expansion will provide a material tailwind in 2025, although disruptions wrought by its startup are likely to negatively impact fourth quarter revenue. Despite the stock moving higher in recent weeks, Materialise remains deeply undervalued. Read the full article on Seeking AlphaArtículo de análisis • Nov 01
Materialise's (NASDAQ:MTLS) Strong Earnings Are Of Good Quality
Materialise NV ( NASDAQ:MTLS ) recently posted some strong earnings, and the market responded positively. We did some...Seeking Alpha • Oct 25
Materialise: Medical Business Unit Is The Hidden Value
Summary Materialise NV is a Belgian additive manufacturing company, showing a 14.18% CAGR in its Medical segment from FY18 to FY23. Despite mixed results in other segments, Materialise maintains profitability with positive FCF and a strong balance sheet, supported by €63 million in net cash. The company's strategic positioning in high-value sectors and steady growth, combined with a net cash position and positive FCF, highlight its upside potential. DCF analysis suggests Materialise is undervalued by 35-40%, justifying a "buy" rating due to its innovative edge and expanding market in healthcare. Read the full article on Seeking AlphaArtículo de análisis • Oct 25
Is There Now An Opportunity In Materialise NV (NASDAQ:MTLS)?
While Materialise NV ( NASDAQ:MTLS ) might not have the largest market cap around , it led the NASDAQGS gainers with a...Seeking Alpha • Aug 01
Materialise Stock: Nearing An Inflection Point (Rating Upgrade)
Summary Materialise NV continues to face headwinds from soft prototyping demand and muted 3D printer sales. Despite this, Materialise reported solid Q2 results, with growth improving sharply. Recent acquisitions, new software launches, and expanded manufacturing capacity are expected to drive growth going forward. While Materialise's share price has moved higher recently, the prospect of solid growth and significantly higher margins are not priced into the stock. Read the full article on Seeking AlphaArtículo de análisis • Aug 01
The Return Trends At Materialise (NASDAQ:MTLS) Look Promising
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Seeking Alpha • Apr 26
Materialise Q1: Progress Against Headwinds
Summary Materialise NV faces a challenging demand environment and is transitioning to a cloud-based SaaS business model, impacting its financial performance. The software business is progressing slowly, while the medical business continues to perform well. The manufacturing business is struggling, but the startup of the expanded ACTech facility later in the year could change this. Macro headwinds and ongoing investments probably limit near-term upside. Longer term, Materialise appears deeply undervalued. Read the full article on Seeking AlphaArtículo de análisis • Apr 19
Materialise's (NASDAQ:MTLS) Strong Earnings Are Of Good Quality
Materialise NV ( NASDAQ:MTLS ) just reported healthy earnings but the stock price didn't move much. Investors are...Seeking Alpha • Feb 26
Materialise: Upside From A Transition To Profitability
Summary The demand environment continues to weigh on Materialise's business, although the Medical segment remains a standout, with strong growth and improving margins. The adoption of robotics in joint replacement surgeries poses a threat to Materialise's medical business, though. Investments in the CO-AM platform and the ACTech facility expansion should begin to pay off in 2024, supporting growth and Materialise's competitive position. Given Materialise's relatively low valuation and the potential for solid growth and improving margins, Materialise's stock should do well over the next 1-2 years. Read the full article on Seeking AlphaArtículo de análisis • Feb 23
Does Materialise (NASDAQ:MTLS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Jan 31
Materialise NV: Consolidation And New Developments To Emerge As A Rising Star In The Additive Manufacturing Industry
Summary Materialise NV currently exhibits better growth, margins and fundamentals than its main competitors, positioning itself well in an industry that is estimated to grow at a CAGR of 16% until 2032; The medical business unit (c.a. 38.5% of total revenues in 9M23) continues to achieve double-digit growth, with the appointment of the new CEO to focus strongly on this segment; Both the analysis of multiples and DCF here presented show that the current share valuation is 40-45% below its fundamental value. Read the full article on Seeking AlphaArtículo de análisis • Jun 14
Here's Why Materialise (NASDAQ:MTLS) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Artículo de análisis • May 23
Returns On Capital At Materialise (NASDAQ:MTLS) Paint A Concerning Picture
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Artículo de análisis • Mar 14
Health Check: How Prudently Does Materialise (NASDAQ:MTLS) Use Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Nov 22
Materialise (NASDAQ:MTLS) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Materialise. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 268 | 10 | 101 | 47 |
| 31 Dec 25 | 268 | 8 | 102 | 46 |
| 30 Sep 25 | 263 | 4 | 102 | 46 |
| 30 Jun 25 | 266 | 6 | 102 | 46 |
| 31 Mar 25 | 270 | 9 | 102 | 46 |
| 31 Dec 24 | 267 | 13 | 101 | 44 |
| 30 Sep 24 | 266 | 10 | 100 | 42 |
| 30 Jun 24 | 258 | 11 | 97 | 41 |
| 31 Mar 24 | 254 | 7 | 95 | 39 |
| 31 Dec 23 | 256 | 7 | 95 | 38 |
| 30 Sep 23 | 254 | 3 | 96 | 39 |
| 30 Jun 23 | 252 | 0 | 98 | 39 |
| 31 Mar 23 | 245 | 1 | 99 | 39 |
| 31 Dec 22 | 232 | -2 | 97 | 38 |
| 30 Sep 22 | 226 | 7 | 94 | 33 |
| 30 Jun 22 | 220 | 14 | 90 | 30 |
| 31 Mar 22 | 213 | 17 | 85 | 28 |
| 31 Dec 21 | 205 | 13 | 82 | 27 |
| 30 Sep 21 | 194 | 6 | 78 | 27 |
| 30 Jun 21 | 182 | -3 | 76 | 26 |
| 31 Mar 21 | 170 | -8 | 73 | 25 |
| 31 Dec 20 | 170 | -7 | 74 | 25 |
| 30 Sep 20 | 176 | -4 | 76 | 24 |
| 30 Jun 20 | 186 | -2 | 80 | 24 |
| 31 Mar 20 | 196 | -1 | 85 | 24 |
| 31 Dec 19 | 197 | 2 | 85 | 23 |
| 30 Sep 19 | 195 | 1 | 85 | 23 |
| 30 Jun 19 | 191 | 2 | 82 | 23 |
| 31 Mar 19 | 188 | 3 | 81 | 22 |
| 31 Dec 18 | 185 | 3 | 79 | 22 |
| 30 Sep 18 | 180 | 4 | 75 | 23 |
| 30 Jun 18 | 166 | 0 | 71 | 22 |
| 31 Mar 18 | 155 | -1 | 67 | 21 |
| 31 Dec 17 | 143 | -2 | 63 | 20 |
| 30 Sep 17 | 129 | -3 | 60 | 19 |
| 30 Jun 17 | 126 | -1 | 59 | 18 |
| 31 Mar 17 | 120 | -1 | 57 | 18 |
| 31 Dec 16 | 114 | -3 | 56 | 18 |
| 30 Sep 16 | 111 | -1 | 55 | 18 |
| 30 Jun 16 | 108 | -3 | 54 | 18 |
| 31 Mar 16 | 105 | -5 | 53 | 18 |
| 31 Dec 15 | 102 | -3 | 52 | 18 |
| 30 Sep 15 | 98 | -5 | 51 | 18 |
Ingresos de calidad: MTLS tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (3.8%) de MTLS son superiores a los del año pasado (3.5%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: MTLS ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 15.1% al año.
Acelerando crecimiento: El crecimiento de los beneficios de MTLS en el último año (8.2%) está por debajo de su media de 5 años (15.1% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de MTLS en el último año (8.2%) no superó al de la industria Software 23.1%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de MTLS (3.9%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/08/12 06:50 |
| Precio de las acciones al final del día | 2026/08/12 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Materialise NV está cubierta por 11 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| John Baliotti | Brean Capital Historical (Janney Montgomery) |
| Robert Burleson | Canaccord Genuity |
| Troy Jensen | Cantor Fitzgerald & Co. |